fig3

Hepatocellular carcinoma tumor immune microenvironment: heterogeneity and therapeutic strategies

Figure 3. Dynamic evolution of immune status across stages of HCC progression. Created in BioRender. HCC: Hepatocellular carcinoma; Treg: regulatory T cell; MDSC: myeloid-derived suppressor cell; TNF: tumor necrosis factor; TGF-β: transforming growth factor-beta; Arg-1: arginase-1; MMPs: matrix metalloproteinases; CXCL12: C-X-C chemokine ligand 12; NO: nitric oxide; ROS: reactive oxygen species.

Hepatoma Research
ISSN 2454-2520 (Online) 2394-5079 (Print)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/